Look into re­ports of vac­cine’s ill ef­fects

The Washington Times Daily - - Opinion -

Although the Amer­i­can Academy of Pe­di­atrics touts there is “ab­so­lutely no sci­en­tific va­lid­ity” to the claim that the HPV vac­cine “is dan­ger­ous,” we at the Al­liance for Nat­u­ral Health USA dis­agree (“Doc­tors call for HPV shots for boys,” Web, Mon­day).

The Cen­ter for Dis­ease Con­trol’s Vac­cine Ad­verse Event Re­port­ing Sys­tem re­ceived a to­tal of 18,727 re­ports of ad­verse events fol­low­ing the Gar­dasil hu­man pa­pil­lo­mavirus (HPV) vac­ci­na­tion. A whopping 1,498 of those events (8 per­cent) were con­sid­ered “se­ri­ous,”in­clud­ing blood clots and neu­ro­log­i­cal dis­or­ders. Un­for­tu­nately, the U.S. gov­ern­ment’s In­sti­tute of Medicine (IOM) has cho­sen to not to in­ves­ti­gate these ad­verse-ef­fect re­ports, say­ing disin­gen­u­ously that they only con­sider peer-re­viewed re­search.

Both the ma­jor me­dia and many of the IOM re­searchers de­pend on the drug com­pa­nies for sup­port, and it ap­pears that we can­not ex­pect any­one in an of­fi­cial po­si­tion even to ac­knowl­edge, much less in­ves­ti­gate, these re­ports sub­mit­ted by doc­tors.

Un­til there is a full in­ves­ti­ga­tion of the nearly 19,000 ad­verse re­ac­tions to the Gar­dasil HPV vac­ci­na­tion, many par­ents should fol­low what the CDC rec­om­mended in 2009 — that the ben­e­fits of giv­ing the HPV vac­cine rou­tinely to 11- to 12-year-old boys doesn’t jus­tify the costs.

DAR­RELL ROGERS

Washington

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.